COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
Public ClinicalTrials.gov record NCT01925794. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
COBRA PZF™ Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term Dual Anti-Platelet Therapy. The PzF Shield Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, multi-center, non-randomized, single arm clinical trial that will be conducted at up to 40 sites in the United States and Outside United States (OUS). This study will enroll patients with symptomatic ischemic heart disease due to a single de novo lesion contained within a native coronary artery with reference vessel diameter between 2.5 mm and 4.0 mm and lesion length ≤ 24 mm that is amenable to percutaneous coronary intervention (PCI) and stent deployment. All patients will be followed at 30 days, 6 months, 9 months, 1 year and annually for 5 years post index stenting procedure.
Study identification
- NCT ID
- NCT01925794
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 296 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2013 (Type not available)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Mar 2, 2020 (Actual)
- Last update posted
- Dec 22, 2021
2013 – 2020
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bakersfield Memorial Hospital | Bakersfield | California | 93303 | — |
| Mt Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Heart Center of Indiana | Indianapolis | Indiana | 46290 | — |
| Louisiana Heart Hospital | Lacombe | Louisiana | 70445 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Deborah Heart & Lung Center | Browns Mills | New Jersey | 08015 | — |
| St Joseph's Hospital | Liverpool | New York | 13088 | — |
| Lenox Hill Hospital | New York | New York | 10075 | — |
| Mount Sinai Hospital | New York | New York | 11029 | — |
| Oklahoma Foundation for Cardiovascular Research | Oklahoma City | Oklahoma | 73120 | — |
| Southern Oregon Cardiology | Medford | Oregon | 97504 | — |
| York General Hospital | York | Pennsylvania | 17403 | — |
| Cardiology Consultants of Texas | Dallas | Texas | 75226 | — |
| Plaza Medical Center | Fort Worth | Texas | 76104 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Texas Cardiac Center | Lubbock | Texas | 79410 | — |
| The Heart Hospital Baylor Plano | Plano | Texas | 75093 | — |
| San Antonio Endovascular & Heart Institute | San Antonio | Texas | 78258 | — |
| Tyler Cardiovascular Consultants | Tyler | Texas | 75701 | — |
| Virginia Cardiovascular Specialists | Richmond | Virginia | 23229 | — |
| Aspirus Heart & Vascular Institute | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01925794, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01925794 live on ClinicalTrials.gov.